The firm and partners Bruce Genderson, Heidi Hubbard, and Adam Perlman have been shortlisted in eight categories for the 2017 LMG Life Sciences Awards:
- Product Liability Firm of the Year
- Antitrust Firm of the Year
- Litigation Firm of the Year
- Hatch-Waxman Litigation Firm of the Year – Branded
- General Patent Litigation Firm of the Year
- Product Liability Attorney of the Year: Heidi Hubbard
- Hatch-Waxman Litigator of the Year – Branded: Adam Perlman
- General Patent Litigator of the Year – District of Columbia: Bruce Genderson
The winners will be announced at the awards ceremony on September 13, at Essex House in New York. The awards, which are selected based on a survey of peers and leading companies in the life sciences industry, “recognize and honor the leading attorneys, firms and in-house counsel teams, which have played a significant role in the life sciences industry over the past year.”
In 2016, the firm received awards for Hatch-Waxman Impact Case of the Year and Patent Impact Case of the Year.
In 2015, the firm was awarded Litigation Firm of the Year, Product Liability Impact Case of the Year, Antitrust Impact Case of the Year and Patent Impact Case of the Year.
Please click here to see a full list of the 2017 LMG Life Sciences Award nominees.
LMG Life Sciences is a part of Euromoney Institutional Investor PLC, which publishes Benchmark: Litigation, Managing Intellectual Property, and International Financial Law Review (IFLR).